Augmedix Inc
NASDAQ:AUGX
Augmedix Inc
NASDAQ:AUGX
Price:
2.35
USD
Market Closed
Market Cap:
$116.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Augmedix Inc
NASDAQ:AUGX
|
US |
|
Nanobiotix SA
PAR:NANO
|
FR |
|
Bark Inc
NYSE:BARK
|
US |
|
Marimekko Oyj
OTC:MKKOF
|
FI |
|
Bizim Toptan Satis Magazalari AS
IST:BIZIM.E
|
TR |
|
Impinj Inc
NASDAQ:PI
|
US |
|
Cambridge Cognition Holdings PLC
LSE:COG
|
UK |
|
Southern Missouri Bancorp Inc
NASDAQ:SMBC
|
US |
|
Calin Technology Co Ltd
TWSE:4976
|
TW |
|
P
|
Parque Arauco SA
SGO:PARAUCO
|
CL |
|
T
|
Tabula Rasa HealthCare Inc
F:43T
|
US |
|
A O Smith Corp
NYSE:AOS
|
US |
|
Y
|
Young Poong Precision Corp
KOSDAQ:036560
|
KR |
Balance Sheet
Balance Sheet Decomposition
Augmedix Inc
Augmedix Inc
Balance Sheet Decomposition is not available for
Augmedix Inc
Augmedix Inc
Balance Sheet
Augmedix Inc
Augmedix Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
10
|
10
|
21
|
41
|
21
|
46
|
|
| Cash |
10
|
10
|
21
|
41
|
21
|
46
|
|
| Total Receivables |
2
|
2
|
3
|
7
|
6
|
9
|
|
| Accounts Receivables |
2
|
2
|
3
|
7
|
6
|
9
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
2
|
3
|
2
|
2
|
2
|
|
| Total Current Assets |
13
|
14
|
27
|
51
|
30
|
57
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
3
|
9
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
3
|
9
|
|
| Accumulated Depreciation |
5
|
6
|
7
|
6
|
6
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Assets |
14
N/A
|
16
+12%
|
28
+77%
|
52
+86%
|
34
-35%
|
67
+98%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
1
|
0
|
1
|
2
|
1
|
|
| Accrued Liabilities |
2
|
3
|
3
|
4
|
6
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
3
|
7
|
2
|
4
|
5
|
|
| Other Current Liabilities |
6
|
7
|
7
|
7
|
8
|
10
|
|
| Total Current Liabilities |
9
|
13
|
16
|
14
|
19
|
24
|
|
| Long-Term Debt |
13
|
10
|
8
|
13
|
11
|
15
|
|
| Other Liabilities |
1
|
4
|
0
|
1
|
1
|
4
|
|
| Total Liabilities |
23
N/A
|
27
+18%
|
25
-8%
|
28
+13%
|
32
+15%
|
43
+35%
|
|
| Equity | |||||||
| Common Stock |
38
|
54
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
50
|
68
|
84
|
101
|
126
|
145
|
|
| Additional Paid In Capital |
3
|
3
|
87
|
125
|
128
|
169
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
9
N/A
|
11
-28%
|
3
N/A
|
24
+671%
|
1
-94%
|
23
+1 486%
|
|
| Total Liabilities & Equity |
14
N/A
|
16
+12%
|
28
+77%
|
52
+86%
|
34
-35%
|
67
+98%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
27
|
27
|
27
|
37
|
37
|
49
|
|
Switch to:
Switch to:
See Also
Discover More
